Philadelphia, PA, United States of America

Bibek Parajuli

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Bibek Parajuli: Innovator in HIV-1 Research

Introduction

Bibek Parajuli is a notable inventor based in Philadelphia, PA. He has made significant contributions to the field of virology, particularly in the treatment and prevention of HIV-1 infections. His innovative work has the potential to impact the lives of many individuals affected by this virus.

Latest Patents

Bibek Parajuli holds a patent for "Compositions for promoting HIV-1 virolysis and methods using same." This invention includes compounds that are useful for treating or preventing an HIV-1 infection in mammals. In certain embodiments, the compounds cause cell-free virolysis of the HIV-1 virus. The invention further includes methods for causing virolysis of the virus using the described compounds. Additionally, it outlines a method for treating or preventing an HIV-1 infection in mammals in need of such treatment.

Career Highlights

Bibek Parajuli is affiliated with Drexel University, where he conducts research and collaborates with other experts in the field. His work is characterized by a commitment to advancing scientific knowledge and developing effective treatments for viral infections.

Collaborations

Some of his notable coworkers include Cameron Frank Abrams and Irwin M Chaiken. Their collaborative efforts contribute to the ongoing research and development in the area of HIV-1 treatment.

Conclusion

Bibek Parajuli's innovative contributions to HIV-1 research exemplify the importance of scientific inquiry in addressing global health challenges. His patent and ongoing work at Drexel University highlight his dedication to improving treatment options for those affected by HIV-1.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…